200 (delivery wire; compatible with Velocity delivery microcatheter [160 cm] and 3MAX reperfusion catheter [153 cm])
Designed for use in combination with ACE and Penumbra JET 7 reperfusion catheters; the architecture enables maximum clot capture capability through four intraluminal chambers and is optimized for use with aspiration delivered by ACE reperfusion catheters or Penumbra JET 7
As part of the Penumbra System, this device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral–M1 and M2 segments) within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Acandis GmbH & Co. KG
Aperio 1.9 F Thrombectomy Device
–
0.010–0.014
30 mm
Thrombectomy device for the mechanical extraction of clots from cerebral vessels with a diameter > 2 and ≤ 4 mm
Intended for use of restoration of the arterial flow for patients diagnosed with ischemic stroke due to large intracranial vessel occlusion (ie, internal carotid artery, M1 and M2 segments of the MCA); patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio device
Acandis GmbH & Co. KG
Aperio 3 F Thrombectomy System
–
0.010–0.014
40 mm
Thrombectomy system (includes microcatheter) for the mechanical extraction of clots from cerebral vessels with a diameter > 2 and ≤ 4 mm
Intended for use of restoration of the arterial flow for patients diagnosed with ischemic stroke due to large intracranial vessel occlusion (ie, internal carotid artery, M1 and M2 segments of the MCA); patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio device
Vesalio Inc.
enVast 4.0 X 30
–
Max: 0.018
30 mm
2 drop zones for clot retrieval; includes a flow restoration zone; indicated for vessels with diameter > 2 mm and ≤ 4 mm; maximal diameter: 4 mm; minimum microcatheter compatibility: 0.021-inch ID
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of thrombosis in the coronary vasculature
Terumo Neuro
Eric Retrieval Device
0.017- and 0.021-inch microcatheter
0.014
15, 20, 24, 30, 35, 44
Clot retriever device with intraluminal clot capture surface
Intended for use in the revascularization of acute ischemic stroke caused by the intracranial occlusive vessels of patients who are not eligible for intravenous tissue plasminogen activator (IV tPA) or who fail IV tPA therapy
Vesalio Inc.
NeVa NET Thrombectomy System 4.0 X 30 mm
Minimum microcatheter ID: 0.021 (1.6 F)
Max: 0.018
Basket working length: 30 mm; basket full length: 49 mm; pusher-wire length: 200 cm
3 drop zones for clot retrieval in acute ischemic stroke; incorporates a braided net on the inside at the distal end of the expandable tip
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of acute ischemic stroke caused by an embolus in a cerebral vessel;
indicated for vessels with diameter > 2.0 mm and ≤ 3.5 mm
Vesalio Inc.
NeVa NET Thrombectomy System 5.5 X 37 mm
Minimum microcatheter ID: 0.027 (2.06 F)
Max: 0.018
Basket working length: 37 mm; basket full length: 56 mm; pusher-wire length: 200 cm
3 drop zones for clot retrieval in acute ischemic stroke; incorporates a braided net on the inside at the distal end of the expandable tip
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of acute ischemic stroke caused by an embolus in a cerebral vessel; Indicated for vessels with diameter > 3.5 mm and ≤ 5.5 mm
Vesalio Inc.
NeVa Thrombectomy System 4.0 X 22 mm
Minimum microcatheter ID: 0.021 (1.6 F)
Max: 0.018
Basket working length: 22 mm, basket full length: 39 mm, pusher wire length: 200 cm
2 drop zones for clot retrieval in acute ischemic stroke
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of acute ischemic stroke caused by an embolus in a cerebral vessel;
Indicated for vessels with diameter > 2.0 mm and ≤ 3.5 mm
Vesalio Inc.
NeVa Thrombectomy System 4.5 X 29 mm
Minimum microcatheter ID: 0.021 (1.6 F)
Max: 0.018
Basket working length: 29 mm, basket full length: 46 mm, pusher wire length: 200 cm
3 drop zones for clot retrieval in acute ischemic stroke
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of acute ischemic stroke caused by an embolus in a cerebral vessel;
Indicated for vessels with diameter > 2.0 mm and ≤ 4.5 mm
Vesalio Inc.
NeVa Thrombectomy System 5.5 X 37 mm
Minimum microcatheter ID: 0.027 (2.06 F)
Max: 0.018
Basket working length: 37 mm, basket full length: 56 mm, pusher wire length: 200 cm
3 drop zones for clot retrieval in acute ischemic stroke
Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of acute ischemic stroke caused by an embolus in a cerebral vessel; Indicated for vessels with diameter > 3.5 mm and ≤ 5.5 mm
Penumbra, Inc. (Neuro)
Penumbra System RED 43, RED 62 Reperfusion Catheter RED 68 Reperfusion Catheter, RED 72 Reperfusion Catheter, RED 72 with SENDit Technology, RED 78
6 (RED 72, RED 72 with SENDit Technology, RED 68, RED 62, RED 43 require 8-F short sheath or 6-F long sheath)
0.014–0.016
132–153
The Penumbra System is designed to remove thrombus and restore blood flow in the neurovasculature using aspiration
Indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Penumbra, Inc. (Neuro)
Penumbra System Reperfusion Catheter ACE, 5MAX, 4MAX, 3MAX
6 (ACE and 5MAX require 8 F short sheath or 6 F long sheath)
0.014–0.016
132–160
Direct aspiration and separator-assisted clot debulking if needed
As part of the Penumbra System, the reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Penumbra, Inc. (Neuro)
Penumbra System Separator and Separator Flex 5MAX, 4MAX, 3MAX
–
–
Separator and separator flex length: 175–200
Separator-assisted clot debulking, if needed
As part of the Penumbra System, the reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
phenox GmbH
Preset Lite Thrombectomy Device
0.0165 inch (ID)
–
180 (insertion wire)
Introduced into the target vessel through a suitable microcatheter and deployed inside the thrombus or distal to the thrombus; after complete deployment the slow withdrawal of the instrument occurs under continuous aspiration via the guiding catheter or aspiration catheter
Designed for mechanical clot retrieval from intracranial arteries as acute ischemic stroke treatment for patients who are ineligible for intravenous thrombolysis or for patients who failed thrombolysis therapy and as a supplement treatment of an initiated thrombolysis therapy
phenox GmbH
Preset Thrombectomy Device
0.021 inch (ID)
–
180 (insertion wire)
Introduced into the target vessel through a suitable microcatheter and deployed inside the thrombus or distal to the thrombus; after complete deployment the slow withdrawal of the instrument occurs under continuous aspiration via the guiding catheter or aspiration catheter
Designed for mechanical clot retrieval from intracranial arteries as acute ischemic stroke treatment for patients who are ineligible for intravenous thrombolysis or for patients who failed thrombolysis therapy and as a supplement treatment of an initiated thrombolysis therapy
Cerenovus
ReVive SE Thrombectomy Device
5 or larger
–
205
Mechanical thrombectomy (stent retriever)
Indicated to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease by providing temporary bypass across the occlusion and/or by the nonsurgical removal of emboli and thrombi; it may be used with aspiration and with the injection or infusion of contrast media and other fluids; the close-ended basket captures clots and large fragments
Terumo Neuro
Sofia Plus Aspiration Catheter
6
–
125, 131
Aspiration catheter
Indicated for general intravascular use, including the peripheral and neurovasculatures; can be used to facilitate introduction of diagnostic or therapeutic agents; not intended for use in coronary arteries; intended for use in the removal/aspiration of emboli and thrombi from selected blood vessels in the arterial system, including the peripheral and neurovasculatures
Rapid Medical
Tigertriever
0.021 inch (ID)
–
220
Incorporates a manually expandable braided distal segment designed to conform to vessel anatomy and thrombus morphology, enabling atraumatic engagement; controlled expansion via the handle allows precise thrombus capture while relieving vascular tension prior to retrieval, promoting safe and effective clot removal
Designed for use in flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Rapid Medical
Tigertriever 13
0.0165/0.013 inch (ID)
–
230
Adjusts to the vasculature and clot providing an atraumatic approach; precise control to capture the thrombus and remove the tension from the vasculature before removal leading to safe and effective procedure; the user can control the manual expansion of the braided distal portion into the clot using the handle component of the device
Designed for use in flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment; designed for use in flow restoration of patients with ischemic stroke due to distal vessel occlusions with a diameter of 1-2 mm
Rapid Medical
Tigertriever 17
0.017 inch (ID)
–
220
Adjusts to the vasculature and clot providing an atraumatic approach; unique operation changes these procedures from a passive to an active user approach that accelerates clot capture and potentially reduces the risk of vascular injury during removal; the user can control the manual expansion of the braided distal portion into the clot using the handle component of the device
Designed for use in flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Rapid Medical
Tigertriever 25
0.025 inch (ID)
–
220
Incorporates a manually expandable braided distal segment designed to conform to vessel anatomy and thrombus morphology, enabling atraumatic engagement; controlled expansion via the handle allows precise thrombus capture while relieving vascular tension prior to retrieval, promoting safe and effective clot removal
Designed for use in flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Rapid Medical
Tigertriever XL
0.021 inch (ID)
–
220
Incorporates a manually expandable braided distal segment designed to conform to vessel anatomy and thrombus morphology, enabling atraumatic engagement; controlled expansion via the handle allows precise thrombus capture while relieving vascular tension prior to retrieval, promoting safe and effective clot removal
Designed for use in flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment
Stryker
Trevo NXT ProVue Retriever; 3 X 25, 4 X 21, 4 X 35, and 6 X 30 mm
8, 9 (balloon guide catheter)
0.014
200 for all stent sizes
Mechanical thrombectomy; 360° of consistently large cells, a soft distal tip, and full-length radiopacity
(1) Indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA); endovascular therapy with the device should start within 6 hours of symptom onset; (2) intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment; (3) indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA)-M1 segments with smaller core infarcts (0-50 mL for age < 80 years, 0-20 mL for age ≥ 80 years); endovascular therapy with the device should start within 6 to 24 hours of time last seen well in patients who are ineligible for IV t-PA or who fail IV t-PA therapy
Stryker
Trevo XP ProVue Retriever; 3 X 20, 4 X 20, 4 X 30, 6 X 25 mm
8, 9 (balloon guide catheter)
0.014
190 for 3 X 20 mm; 180 for 4 X 20 mm, 4 X 30 mm, and 6 X 25 mm
Mechanical thrombectomy; 360° of consistently large cells, a soft distal tip and full-length radiopacity
Indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large-vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA); endovascular therapy with the device should start within 6 hours of symptom onset; intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment Indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large-vessel occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA)-M1 segments with smaller-core infarcts (0–50 mL for age < 80 years, 0–20 mL for age ≥ 80 years); endovascular therapy with the device should start within 6–24 hours of time last seen well in patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!